Fieldview Capital Management’s Oracle ORCL Stock Holding History

Fieldview Capital Management’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30,885	Closed	-$8.69M	–	596
2025 Q3	$8.69M	Buy	+30,885	New	+$7.87M	1.42%	2

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fieldview Capital Management's ORCL Position: Q4 2025 in Review

Fieldview Capital Management sold out of Oracle (ORCL) in Q4 2025, closing a stake of 30,885 shares — an estimated $8.69M sold.

Fieldview Capital Management first reported a position in ORCL in Q3 2025 and held it in 1 quarter. The position peaked at $8.69M in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Fieldview Capital Management reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Fieldview Capital Management sold 30,885 Oracle shares in Q4 2025, an estimated $8.69M.
Fieldview Capital Management first reported a position in Oracle in Q3 2025 and held it in 1 quarter.
Fieldview Capital Management's Oracle position peaked at $8.69M in Q3 2025.
3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.